I am currently pursuing a PhD as part of the ProgRET Marie Skłodowska-Curie Actions Doctoral Network, a consortium dedicated to the understanding, diagnosis, and treatment of autosomal dominant inherited retinal diseases. My research focuses on developing allele-specific invalidation therapy for autosomal dominant CRX mutations, which I am working on at the Institut for Neurosciences of Montpellier (INM). I am passionate about advancing therapeutic solutions in genetic retinal disorders and look forward to connecting with professionals in this field. For more information, please visit our project website: https://www.progret.eu/.